CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE

Post-LOE

amitriptyline hydrochloride; chlordiazepoxide

Molecular Devices

ANDAORALTABLET

Approved

Dec 1986

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

3/8 — Basic

CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE (amitriptyline hydrochloride; chlordiazepoxide) by Molecular Devices is clinical pharmacology both components of chlordiazepoxide and amitriptyline hydrochloride tablets exert their action in the central nervous system. Approved for depression, anxiety, insomnia. First approved in 1986.

Drug data last refreshed 20h ago

Mechanism of Action

CLINICAL PHARMACOLOGY Both components of chlordiazepoxide and amitriptyline hydrochloride tablets exert their action in the central nervous system. Extensive studies with chlordiazepoxide in many animal species suggest action in the limbic system. Recent evidence indicates that the limbic system is…

Indications (3)

depression anxiety

Worked on CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE at Molecular Devices? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.